Skip to content
Contact
Keep up-to-date
with us
Category: Stakeholder
Unlocking the Future of Type 1 Diabetes Care: Why Earlier Diagnosis Must Match Innovation in Treatment
-
15/10/2025
Webinar: How AI-driven insights from RWD accelerate the diagnosis and treatment of undiagnosed patients: a case study
-
05/09/2025
Optimising Rare Disease Clinical Trials with Real World Data Using NLP & AI: Volv Global at the Rare Trials Summit 2025
-
25/08/2025
Beyond Quick Fixes: How Predictive Modelling Can Redefine Clinical Trial Enrolment
-
21/08/2025
Beyond Initial Treatment: Navigating Recurrence Risk and Clinical Decisions in Cancer Survivors
-
08/07/2025
Unlocking the Full Impact of Breakthrough Therapies in Breast Cancer Through Earlier Detection
-
27/06/2025
Progressive Pulmonary Fibrosis: Solving the Puzzle of Poor Disease Control
-
23/06/2025
A Rare Disease Day Message from Dr. Al Freedman
-
28/02/2025
ATS 2024: Poster on Alpha-1 Antitrypsin Deficiency – Why millions remain undiagnosed
-
13/05/2024
Finding Patients for Rare Diseases: A Case Study
-
01/01/2024
How we help you
Clinical Development
Value and Access, HEOR
Medical Affairs
Commercial Excellence
inTrigue
inTrigue
What we do
Finding patients
Earlier detection
Predicting patient outcomes
Stratifying patient cohorts
Knowledge Hub
Insights
Case Studies
Events
News
Articles
Patient Resources
Meet Volv Global
Meet Volv Global
FAQ
How we help you
Clinical Development
Value and Access, HEOR
Medical Affairs
Commercial Excellence
inTrigue
What we do
Finding patients
Earlier detection
Predicting patient outcomes
Stratifying patient cohorts
Knowledge Hub
Insights
Case Studies
Events
News
Articles
Patient Resources
Meet Volv Global
Meet Volv Global
FAQ